Online citations, reference lists, and bibliographies.
← Back to Search

Stimulation Of Kupffer Cell Tumoricidal Activity By Liposomal Muramyl Dipeptides.

N. Phillips
Published 1992 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1016/0304-4165(81)90148-3
The involvement of parenchymal, Kupffer and endothelial liver cells in the hepatic uptake of intravenously injected liposomes. Effects of lanthanum and gadolinium salts.
F. Roerdink (1981)
10.1016/0008-8749(79)90131-X
Direct augmentation of cytolytic activity of tumor-derived macrophages and macrophage cell lines by muramyl dipeptide.
T. Taniyama (1979)
10.1016/0304-4165(81)90341-X
In vivo fate of large unilamellar sphingomyelin-cholesterol liposomes after intraperitoneal and intravenous injection into rats.
H. Ellens (1981)
10.1073/PNAS.72.10.4105
Comparison between macrophage activation and enhancement of nonspecific resistance to tumors by mycobacterial immunoadjuvants.
D. Juy (1975)
10.1016/0006-291X(75)90503-3
Total synthesis and adjuvant activity of bacterial peptidoglycan derivatives.
C. Merser (1975)
Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages.
I. Fidler (1980)
Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery.
G. Poste (1982)
10.1089/SCT.1990.6.63
Therapy of murine liver metastases by administration of MDP encapsulated in liposomes.
T. Daemen (1990)
Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
N. Phillips (1987)
10.1083/JCB.106.3.925
Inhibition of in vitro tumor cell invasion by Arg-Gly-Asp-containing synthetic peptides [published erratum appears in J Cell Biol 1989 Jun;108(6):following 2546]
K. R. Gehlsen (1988)
Metastatic patterns in patients with carcinomas of the lower esophagus and upper rectum.
L. Weiss (1984)
10.1038/271372a0
Novel treatment for joint inflammation
J. Dingle (1978)
10.1073/PNAS.78.3.1680
Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide.
I. Fidler (1981)
Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide.
S. Sone (1982)
10.1158/AJC.1934.99
Cancer Cells in the Blood Stream
E. H. Pool (1934)
10.1016/0006-291X(74)90458-6
Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives.
F. Ellouz (1974)
Inhibition of experimental liver tumor growth in mice by liposomes containing a lipophilic muramyl dipeptide derivative.
N. Phillips (1989)
10.1097/00000421-198904000-00023
Monokines and Other Non-Lymphocytic Cytokines
M. Powanda (1989)
10.1172/JCI113753
Interleukin 1 promotes tumor cell adhesion to cultured human endothelial cells.
E. Dejana (1988)
10.1016/0192-0561(83)90059-0
Modulation of murine lymphoma growth by MDP, MDP(D-D) and cyclophosphamide. 1. Inhibition of growth in vivo.
N. Phillips (1983)
Specificity of adhesion between murine tumor cells and capillary endothelium: an in vitro correlate of preferential metastasis in vivo.
R. Auerbach (1987)
In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide.
T. Daemen (1986)
10.1172/JCI113384
Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells.
M. Humphries (1988)
The dissemination of cancer cells.
W. H. Cole (1958)
Activation of macrophage cytostatic and cytotoxic activity in vitro by liposomes containing a new lipophilic muramyl peptide derivative, MDP-L-alanyl-cholesterol (MTP-CHOL).
N. Phillips (1985)
10.1002/PATH.1711500308
Haematogenous metastastic patterns in colonic carcinoma: An analysis of 1541 necropsies
L. Weiss (1986)
Efficacy of liposomes containing a lipophilic muramyl dipeptide derivative for activating the tumoricidal properties of alveolar macrophages in vivo
I. Fidler (1982)
Inhibitory effects of DN-9693 on platelet-enhanced tumor cell attachment to cultured endothelium.
A. Tohgo (1990)
10.1002/HEP.1840080511
Activation of murine kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide
N. Phillips (1988)
10.1136/ard.38.6.553
Liposome-incorporated corticosteroids. II. Therapeutic activity in experimental arthritis.
N. C. Phillips (1979)
10.1093/JNCI/69.5.1189
Isolation of tumoricidal macrophages from lung melanoma metastases of mice treated systemically with liposomes containing a lipophilic derivative of muramyl dipeptide.
M. Key (1982)
10.1016/0192-0561(84)90068-7
Modulation of the growth of murine thymoma cell lines having different Lyt-phenotypes by MDP and MDP(D-D): macrophage-mediated inhibition of in vitro cell growth.
N. Phillips (1984)
The activation of human monocytes by liposome-encapsulated muramyl dipeptide analogues.
G. López-Berestein (1983)
10.1016/0192-0561(85)90071-2
In vitro inhibition of murine B-cell tumor growth by MDP, MDP(D-D) and Vaccin is mediated by macrophages.
M. Moras (1985)
Activation of alveolar macrophage tumoricidal activity and eradication of experimental metastases by freeze-dried liposomes containing a new lipophilic muramyl dipeptide derivative.
N. Phillips (1985)
Induction of tumoricidal activity in isolated rat liver macrophages by liposomes containing recombinant rat gamma-interferon supplemented with lipopolysaccharide or muramyldipeptide.
M. J. Stukart (1987)
10.1016/0008-8749(81)90118-0
In vitro activation of tumoricidal properties in rat alveolar macrophages by synthetic muramyl dipeptide encapsulated in liposomes.
S. Sone (1981)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar